Search

Coller, H. A., C. Grandori, P. Tamayo, T. Colbert, E. S. Lander, R. N. Eisenman, and T. R. Golub. 2000. “Expression Analysis With Oligonucleotide Microarrays Reveals That MYC Regulates Genes Involved in Growth, Cell Cycle, Signaling, and Adhesion”. Proc Natl Acad Sci U S A 97: 3260-5.

Ebert, B. L., and T. R. Golub. 2004. “Genomic Approaches to Hematologic Malignancies”. Blood 104: 923-32.

Feuerhake, F., J. L. Kutok, S. Monti, W. Chen, A. S. LaCasce, G. Cattoretti, P. Kurtin, et al. 2005. “NFkappaB Activity, Function, and Target-Gene Signatures in Primary Mediastinal Large B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Subtypes”. Blood 106: 1392-9.

Golub, T. R. 1997. “TEL Gene Rearrangements in Myeloid Malignancy”. Hematol Oncol Clin North Am 11: 1207-20.

Golub, T. R. 2001. “Genomic Approaches to the Pathogenesis of Hematologic Malignancy”. Curr Opin Hematol 8: 252-61.

Green, M. R., S. Monti, S. J. Rodig, P. Juszczynski, T. Currie, E. O’Donnell, B. Chapuy, et al. 2010. “Integrative Analysis Reveals Selective 9p24.1 Amplification, Increased PD-1 Ligand Expression, and Further Induction via JAK2 in Nodular Sclerosing Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma”. Blood 116: 3268-77.

Guo, S., J. Lu, R. Schlanger, H. Zhang, J. Y. Wang, M. C. Fox, L. E. Purton, et al. 2010. “MicroRNA MiR-125a Controls Hematopoietic Stem Cell Number”. Proc Natl Acad Sci U S A 107: 14229-34.

Haining, W. N., B. L. Ebert, A. Subrmanian, E. J. Wherry, Q. Eichbaum, J. W. Evans, R. Mak, et al. 2008. “Identification of an Evolutionarily Conserved Transcriptional Signature of CD8 Memory Differentiation That Is Shared by T and B Cells”. J Immunol 181: 1859-68.

Hoshida, Y., A. Villanueva, M. Kobayashi, J. Peix, D. Y. Chiang, A. Camargo, S. Gupta, et al. 2008. “Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma”. N Engl J Med 359: 1995-2004.

Stanbrough, M., G. J. Bubley, K. Ross, T. R. Golub, M. A. Rubin, T. M. Penning, P. G. Febbo, and S. P. Balk. 2006. “Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer”. Cancer Res 66: 2815-25.